U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Did You Know...

...Daniel Webster invented a "bull plow" to pull out tree stumps. It didn't catch on because it was huge and required four oxen to pull it!

Newsletter  PatentStorm News

Make the Most of PatentStorm

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest patents by subscribing to an RSS feed.

Got questions? Ask a Patent Expert!

Registered users: Manage your profile, comments and alerts.

 

US Patent 5538866 - Prostate-specific membrane antigen

US Patent Issued on July 23, 1996
Estimated Patent Expiration Date: Icon_subject October 18, 2014Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
loading...


View Patent Images (PDF)
(Registered users only)

Abstract

This invention provides an isolated mammalian nucleic acid molecule encoding a mammalian prostate-specific membrane antigen. This invention also provides prostate-specific membrane nucleic acid of at least 15 nucleotides capable of specifically hybridizing with a sequence of a nucleic acid molecule encoding a mammalian prostate-specific membrane antigen. This invention further provides vector and vector host expression system for the prostate-specific membrane antigen. This invention also provides methods to identify ligands which bind to the prostate-specific membrane antigen, to generate antibody against a complete prostate-specific membrane antigen or a portion of the antigen. This invention further provides purified prostate-specific membrane antigen. This invention provides a therapeutic agent comprising an antibody directed against to prostate-specific membrane antigen and a cytotoxic agent conjugated thereto. This invention also provides a method of imaging prostate cancer and an immunoassay for measuring the amount of the prostate-specific membrane antigen in a biological sample. This invention further provides transgenic nonhuman mammal which comprises the isolated nucleic acid molecule encoding a mammalian prostate-specific membrane antigen.

Other References

  • Israeli et al. Cancer Res. 53:227-30, Jan. 1993
  • Watt et al. PNAS 83:3166-70, May 1986
  • Sambrook et al. Molecular Cloning, A Laoboratory Manual, published by Cold Spring Harbor Laboratory Press, 1989, see chapter 16
  • Bowie et al. Science 247:1306-1310 1990
  • Axelrod, H. R., et al., Preclinical results and human immunohistochemical studies with 90 Y-CYT-356. A new prostate cancer agent. Abstract 596. AUA 87th Annual Meeting, May 10-14, 1992. Washington, D. C. (1968)
  • Henttu, P., et al. (1989) cDNA coding for the entire human prostate specific antigen show high homologies to the human tissue kallikrein genes. Bioch. Biophys. Res. Comm. 160:903-908
  • Horoszewicz, J. S., et al. (1987) Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells an serum of prostatic cancer patients. Anticancer Res. 7:927-936. (Exhibit 5)
  • Wright, Jr., G. L., et al. (1990) Characterization of a new prostate carcinoma-associated marker: 7E11-C5. Anitbod. Immunoconj. Radiopharm. 3: (abst#193) (Exhibit 7)
  • Culver, K. W., et al. (1992) "In Vivo Gene Transfer With Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors", Science 256:1550-1552
  • Decensi, A., et al. (1991) "Phase II Study of the Pure Non-Steroidal Antiandrogen Nilutamide in Prostatic Cancer", Eur. J. Cancer 27:1100-1104
  • Feng, Q., et al. (1991) "Purification and Biochemical Characterization of the 7E11-C5 Prostate Carcinoma-Associated Antigen", Proceeding of the 82nd Annual Meeting of the American Association for Cancer Research, 32:239
  • Fey, M. F., et al. (1991) "The Polymerase Chain Reaction: A new tool for the Detection of Minimal Residual disease in Haematological Malignancies", Eur. J. Cancer 27:89-94
  • Gately, M. K., et al. (1992) "Regulation of Human Cytolytic Lymphocyte Responses by Interleukin-12", Cellular Immunology 143:127-142
  • Huber, B. E., et al. (1991) "Retroviral-Mediated Gene Therapy For the Treatment of Hepatocellular Carcinoma: An Innovative Approach For Cancer Therapy" Proc. Natl. Acad. Sci. USA 88:8039-8043
  • Keer, H. N., et al. (1990) "Elevated Transferrin Receptor Content in Human Prostate Cancer Cell Lines Assessed In Vitro and In Vivo", J. Urology 143:381-385
  • Lopes, A. D., et al. (1990) "Immunohistochemical And Pharmacokinetic Characterization of the Site-Specific Immunoconjugate CYT-356 Derived From Anitprostate Monoclonal Antibody 7E11-C5", Cancer Research 50:6423-6429
  • Mukhopadhyay, T., et al. (1991) "Specific Inhibition of K-ras Expression and Tumorigenicity of Lung Cancer Cells by Antisense RNA", Cancer Research 51:1744-1748
  • Paul, W. E. (1989) "Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)", Fundamental Immunology, 2ed, Raven Press, New York pp. 628-651
  • Rose, N. R., et al. (1986) "Solving and Preventing Problems in Ligand Assay", Manual of Clinical Laboratory Immunology, American Society for Microbiology, Washington, D.C. pp. 88-109
  • Solin, T., et al. (1990) "Gene Expression and Prostate Specificity of Human Prostatic acid Phosphatase (PAP): Evaluation by RNA Blot Analyses", Biochimica et Biophysica Acta 1048:72-77
  • Stites, D. P. and Terr, A. I. (1991) "Climical Laboratory Methods for Detection of Antigens and Anitbodies", Basic and Clinical Immunology, Appleton & Lange, Norwalk, pp. 229-251
  • Tortora, G. J., et al. (1989) "Specific Defenses of the Host: The Immune Response", Microbiology: An Introduction, The Benjamin/Cummings Publishing Company, Inc. pp. 423-471
  • Vile, R. G. and Hart, I. R. (1993) "In Vitro and In Vivo Targeting of Gene Expression to Melanoma Cells", Cancer Research 53:962-967
  • Young, R. A. and Davis, R. W. (1983) "Efficient Isolation of Genes by Using Antibody Probes", Proc. Natl. Acad. Sci. USA 80:1194-1198
  • Faber, P. W., et al. (1991) "Characterization of the Human Androgen Receptor Transcription Unit", J. Biol. Chem. 266:10743-1074

Inventors

Application

No. 325553 filed on 10/18/1994

US Classes:

435/69.3, Antigens435/252.3, Transformants (e.g., recombinant DNA or vector or foreign or exogenous gene containing, fused bacteria, etc.)435/254.2, Yeast; media therefor435/320.1, VECTOR, PER SE (E.G., PLASMID, HYBRID PLASMID, COSMID, VIRAL VECTOR, BACTERIOPHAGE VECTOR, ETC.) BACTERIOPHAGE VECTOR, ETC.)435/325, ANIMAL CELL, PER SE (E.G., CELL LINES, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A COMPOSITION CONTAINING AN ANIMAL CELL; CULTURE MEDIA THEREFORE435/348, Insect cell, per se536/23.5Encodes an animal polypeptide

Field of Search

435/69.3, Antigens435/320.1, VECTOR, PER SE (E.G., PLASMID, HYBRID PLASMID, COSMID, VIRAL VECTOR, BACTERIOPHAGE VECTOR, ETC.) BACTERIOPHAGE VECTOR, ETC.)435/252.3, Transformants (e.g., recombinant DNA or vector or foreign or exogenous gene containing, fused bacteria, etc.)435/254.2, Yeast; media therefor536/23.5Encodes an animal polypeptide

Examiners

Primary: Mosher, Mary E.
Assistant: Caputa, Anthony C.

Attorney, Agent or Firm

US Patent References

4554101Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
Issued on: 11/19/1985
Inventor: Hopp

International Classes

C12N 015/12
C12N 001/21
C12P 071/02

Comments

No comments for this page
 
 
Forgot password?
Register here